Company profile: Provision Healthcare
1.1 - Company Overview
Company description
- Provider of cancer care and proton therapy, offering the ProNova SC360 system (360° treatment with superconducting magnets), integrated dual-energy CBCT for IGRT, fast-scanning IMPT, an independent energy selection system for instantaneous room switching, SBRT, and ARC radiation therapy, with a focus on improving patient care, outcomes, research, education, and charitable causes.
Products and services
- ProNova SC360 Proton Therapy System: Engineers precise proton beam delivery with a compact 360° treatment angle and superconducting magnet technology for advanced cancer treatments
- Fast-Scanning IMPT: Produces rapid layer painting using high-frequency scanning magnets, accelerating intensity-modulated proton therapy delivery across tumor volumes to reduce overall treatment times
- Advanced Imaging: Delivers integrated dual-energy CBCT for precise imaging, enabling advanced IGRT and multiple field treatment from a single image acquisition
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Provision Healthcare
RedPath Integrated Pathology
HQ: United States
Website
- Description: Provider of reference laboratory services and oncology case support, offering PathFinderTG, a testing platform for resolving diagnoses from the original pathology specimen, serving pathologists, clinicians, and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RedPath Integrated Pathology company profile →
Modifi Bio
HQ: United States
Website
- Description: Provider of direct DNA modification cancer therapeutics, including orally delivered molecules that selectively kill cancer cells by modifying tumor DNA while preserving healthy cells. Products target cancers with DNA repair defects and MGMT deficiency, with applications in glioblastomas, gliomas, and potentially other MGMT-deficient tumor types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modifi Bio company profile →
Proteovant Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology solutions utilizing protein degradation research to develop medicines for diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proteovant Therapeutics company profile →
Oncogeni
HQ: United Kingdom
Website
- Description: Provider of novel cell- and RNA-based cancer medicines, specializing in small interfering RNA and mesodermal killer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncogeni company profile →
Arius Research
HQ: Canada
Website
- Description: Provider of biotechnology solutions centered on the discovery and development of antibody therapeutics, primarily targeting breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia, and melanoma, leveraging its FunctionFIRST platform to identify monoclonal antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arius Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Provision Healthcare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Provision Healthcare
2.2 - Growth funds investing in similar companies to Provision Healthcare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Provision Healthcare
4.2 - Public trading comparable groups for Provision Healthcare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →